...
search icon
zntl-img

Zentalis Pharmaceuticals Llc Share Price

ZNTL
NMQ
$2.39
+$0.05
(2.14%)
1D
Industry: Biotechnology Sector: Health Care

Zentalis Pharmaceuticals Llc Analyst Forecast

Zentalis Pharmaceuticals Llc Share Price Chart

Zentalis Pharmaceuticals Llc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$154.75M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
245.31K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.72
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.01 L
$3.95 H
$2.39

About Zentalis Pharmaceuticals Llc, Common Stock

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California. more

Industry: BiotechnologySector: Health Care

Zentalis Pharmaceuticals Llc Stock Returns

Time FrameZNTLSectorS&P500
1-Week Return--0.03%-1.38%
1-Month Return-31.32%0.59%-1.81%
3-Month Return81.06%3.23%1.38%
6-Month Return60.4%18.29%5.68%
1-Year Return-1.65%7.71%11.74%
3-Year Return-88.32%18.03%65.15%
5-Year Return-93.66%35.78%73.68%
10-Year Return-89.7%140.42%260.03%

Zentalis Pharmaceuticals Llc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue----67.42M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue160.00K544.00K1.43M1.39M1.29M[{"date":"2020-12-31","value":11.22,"profit":true},{"date":"2021-12-31","value":38.15,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":97.41,"profit":true},{"date":"2024-12-31","value":90.39,"profit":true}]
Gross Profit(160.00K)(544.00K)(1.43M)(1.39M)67.42M[{"date":"2020-12-31","value":-0.24,"profit":false},{"date":"2021-12-31","value":-0.81,"profit":false},{"date":"2022-12-31","value":-2.11,"profit":false},{"date":"2023-12-31","value":-2.06,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin----100.00%[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses118.79M216.54M227.29M299.51M258.62M[{"date":"2020-12-31","value":39.66,"profit":true},{"date":"2021-12-31","value":72.3,"profit":true},{"date":"2022-12-31","value":75.89,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":86.35,"profit":true}]
Operating Income(118.79M)(216.54M)(227.29M)(299.51M)(191.19M)[{"date":"2020-12-31","value":-11878700000,"profit":false},{"date":"2021-12-31","value":-21654200000,"profit":false},{"date":"2022-12-31","value":-22728700000,"profit":false},{"date":"2023-12-31","value":-29950900000,"profit":false},{"date":"2024-12-31","value":-19119400000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(118.10M)(166.39M)(237.58M)(292.91M)(165.69M)[{"date":"2020-12-31","value":-11810400000,"profit":false},{"date":"2021-12-31","value":-16639000000,"profit":false},{"date":"2022-12-31","value":-23758200000,"profit":false},{"date":"2023-12-31","value":-29290600000,"profit":false},{"date":"2024-12-31","value":-16569000000,"profit":false}]
Income Taxes444.00K(297.00K)(469.00K)(601.00K)177.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-66.89,"profit":false},{"date":"2022-12-31","value":-105.63,"profit":false},{"date":"2023-12-31","value":-135.36,"profit":false},{"date":"2024-12-31","value":39.86,"profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(118.55M)(164.26M)(220.83M)(286.35M)(165.87M)[{"date":"2020-12-31","value":-11854800000,"profit":false},{"date":"2021-12-31","value":-16426200000,"profit":false},{"date":"2022-12-31","value":-22083100000,"profit":false},{"date":"2023-12-31","value":-28635000000,"profit":false},{"date":"2024-12-31","value":-16586700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(117.84M)(158.72M)(236.81M)(292.19M)(165.84M)[{"date":"2020-12-31","value":-11784100000,"profit":false},{"date":"2021-12-31","value":-15872500000,"profit":false},{"date":"2022-12-31","value":-23680600000,"profit":false},{"date":"2023-12-31","value":-29219100000,"profit":false},{"date":"2024-12-31","value":-16583900000,"profit":false}]
EPS (Diluted)(5.58)(4.94)(4.53)(4.64)(2.27)[{"date":"2020-12-31","value":-558,"profit":false},{"date":"2021-12-31","value":-494,"profit":false},{"date":"2022-12-31","value":-453,"profit":false},{"date":"2023-12-31","value":-464,"profit":false},{"date":"2024-12-31","value":-227.38,"profit":false}]

Zentalis Pharmaceuticals Llc Ratios

Zentalis Pharmaceuticals Llc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

ZNTL
Cash Ratio 7.55
Current Ratio 7.76

Zentalis Pharmaceuticals Llc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ZNTL
ROA (LTM) -24.51%
ROE (LTM) -49.18%

Zentalis Pharmaceuticals Llc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ZNTL
Debt Ratio Lower is generally better. Negative is bad. 0.23
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.77

Zentalis Pharmaceuticals Llc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ZNTL
Trailing PE NM
Forward PE NM
P/S (TTM) 5.76
P/B 0.61
Price/FCF NM
EV/R 7.77
EV/Ebitda NM

FAQs

What is Zentalis Pharmaceuticals Llc share price today?

Zentalis Pharmaceuticals Llc (ZNTL) share price today is $2.39

Can Indians buy Zentalis Pharmaceuticals Llc shares?

Yes, Indians can buy shares of Zentalis Pharmaceuticals Llc (ZNTL) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ZNTL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Zentalis Pharmaceuticals Llc be purchased?

Yes, you can purchase fractional shares of Zentalis Pharmaceuticals Llc (ZNTL) via the Vested app. You can start investing in Zentalis Pharmaceuticals Llc (ZNTL) with a minimum investment of $1.

How to invest in Zentalis Pharmaceuticals Llc shares from India?

You can invest in shares of Zentalis Pharmaceuticals Llc (ZNTL) via Vested in three simple steps:

  • Click on Sign Up or Invest in ZNTL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Zentalis Pharmaceuticals Llc shares
What is Zentalis Pharmaceuticals Llc 52-week high and low stock price?

The 52-week high price of Zentalis Pharmaceuticals Llc (ZNTL) is $3.95. The 52-week low price of Zentalis Pharmaceuticals Llc (ZNTL) is $1.01.

What is Zentalis Pharmaceuticals Llc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Zentalis Pharmaceuticals Llc (ZNTL) is

What is Zentalis Pharmaceuticals Llc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Zentalis Pharmaceuticals Llc (ZNTL) is 0.61

What is Zentalis Pharmaceuticals Llc dividend yield?

The dividend yield of Zentalis Pharmaceuticals Llc (ZNTL) is 0.00%

What is the Market Cap of Zentalis Pharmaceuticals Llc?

The market capitalization of Zentalis Pharmaceuticals Llc (ZNTL) is $154.75M

What is Zentalis Pharmaceuticals Llc's stock symbol?

The stock symbol (or ticker) of Zentalis Pharmaceuticals Llc is ZNTL

How Can Investors Use Zentalis Pharmaceuticals Llc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Zentalis Pharmaceuticals Llc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Zentalis Pharmaceuticals Llc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Zentalis Pharmaceuticals Llc shares for Indian investors?

When investing in Zentalis Pharmaceuticals Llc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Zentalis Pharmaceuticals Llc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Zentalis Pharmaceuticals Llc share price with other stocks in the same sector?

Rather than merely checking the share price of Zentalis Pharmaceuticals Llc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Zentalis Pharmaceuticals Llc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top